Disc Medicine stock is hit by an FDA CRL for bitopertin. Learn key trial risks, cash runway, and why APOLLO Phase 3 results ...
During a live event, Hagen Kennecke, MD, discusses how RADIANT-4 and NETTER trials have reshaped NET care with everolimus and PRRT.
This study provides a useful contribution to understanding how wearable augmentation devices interact with human proprioception, using a longitudinal design over a single session. Results demonstrate ...
Some say we’ve entered a new age of AI-enabled scientific discovery. But human insight and creativity still can’t be ...
It has been over a month since Hytale released into early access, and development has been going strong. The developers have ...
Military service members and veterans frequently experience post-traumatic stress disorder (PTSD), which is linked to a range of psychological challenges and adverse effects. Cognitive-behavioral ...
DUI arrests made by a single Tennessee Highway Patrol trooper in Bedford County have been dismissed — and in more than half ...
Vistagen (Nasdaq: VTGN), a late clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commercialize a new class of intranasal product ...
Check out the latest features introduced in the Hytale patch notes for update 3 including animal taming, map markers and creative hub changes ...
A year of turbulence has exposed the dangers of philanthropic monocultures and upended assumptions about impact, effectiveness, and scale. Embracing the varied intentions that motivate people to give ...
Tarique Rahman, the scion of a political dynasty, is set to become the prime minister. This was the first election in Bangladesh since student-led protests toppled the last government in 2024.
By far the strongest genetic risk factor for Alzheimer’s disease is a variant of apolipoprotein E, or ApoE. People who carry ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results